Istituto Oncologico Veneto Irccs
Clinical trials sponsored by Istituto Oncologico Veneto Irccs, explained in plain language.
-
New dressing aims to cut wound issues in limb sarcoma surgery
Disease control Recruiting nowThis study tests whether a single-use negative pressure wound dressing (PICO 14) can reduce wound complications after surgery for soft tissue sarcoma in the arms or legs. The trial involves 48 adults who have had radiation therapy before surgery. Participants are randomly assigne…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 26, 2026 02:28 UTC
-
Electric shocks and chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for people with tumors in organs like the liver or pancreas that cannot be removed by surgery. The treatment uses short electric pulses to help chemotherapy drugs enter cancer cells more effectively. The goal is to shrink tu…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Milk thistle compound tested against brain cancer in new trial
Disease control Recruiting nowThis study tests whether adding silibinin (a milk thistle extract) to standard chemoradiation and maintenance therapy can delay tumor growth in people with a specific type of newly diagnosed glioblastoma. About 110 participants will receive either silibinin or a placebo alongside…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for brain tumor patients: drug shows promise in slowing recurrent meningioma
Disease control Recruiting nowThis study tests a drug called regorafenib in people whose meningioma (a type of brain tumor) has come back after previous treatment. The drug works by blocking blood vessel growth and other signals that help tumors grow. About 104 participants will receive the drug to see if it …
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Virtual reality goggles could replace pills for procedure pain
Symptom relief Recruiting nowThis study tests whether using a virtual reality headset (REALICA) can lower pain and anxiety in people having common urology procedures like prostate biopsy, cystoscopy, or circumcision. About 56 adults will use the VR device during their procedure and report their anxiety and p…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated May 26, 2026 02:32 UTC
-
New bladder rinse aims to make cancer treatment easier on patients
Symptom relief Recruiting nowThis study tests whether a bladder rinse called Hydeal Cyst® can reduce urinary symptoms in people with non-muscle invasive bladder cancer who are receiving standard chemotherapy or immunotherapy. About 200 adults will receive either standard treatment alone or standard treatment…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Scientists target cancer Cells' weakness in new trial
Knowledge-focused Recruiting nowThis study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that attack cancer cells by changing their internal balance of reactive oxygen species (ROS). The goal is to find which drug combinations wo…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 02:29 UTC
-
Scientists dive deep into Mesothelioma's immune secrets
Knowledge-focused Recruiting nowThis study looks at tumor samples from 220 people with pleural or peritoneal mesothelioma, a rare cancer linked to asbestos. Researchers will analyze genes and immune cells in the tumors to find patterns that predict which treatments work best. The goal is to pave the way for mor…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC
-
New scarless breast surgery could change cancer care
Knowledge-focused Recruiting nowThis study reviews a new type of breast-conserving surgery that uses the body's own tissue to fill the area where the tumor was removed, leaving no visible scars. Researchers will look at medical records from 250 women treated in the last 10 years to see how well the surgery work…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC